Monika Engelhardt
University of Freiburg(DE)University Medical Center Freiburg(DE)Comprehensive Blood & Cancer Center(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology, Peptidase Inhibition and Analysis, Acute Myeloid Leukemia Research
Most-Cited Works
- → Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma(2019)662 cited
- → Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group(2017)506 cited
- → Strength and muscle mass loss with aging process. Age and strength loss(2019)495 cited
- → Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology(2004)487 cited
- → European Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications(2015)391 cited
- → Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial(2019)376 cited